Adv Radiat Oncol 2020 Sep-Oct
Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal Adenocarcinoma.
Related Questions
New answer by Radiation Oncologist at Mayo Clinic School of Medicine (February 17, 2022)
I agree completely with @Joel E. Tepper.Here’s a multi-institutional series suggesting 3-year OS and PFS of 80% and 60% amongst a predominately elderly, high comorbidity...